Transvaginal ultrasound is the only imaging option for diagnosing PCOS
the verdict
REFUTED
the evidence says no
confidence 6/100
Transvaginal ultrasound is not the only imaging or diagnostic option for polycystic ovary syndrome (PCOS), as magnetic resonance imaging and biochemical markers such as anti-Müllerian hormone are also successfully utilized for diagnosis.
Evidence against · 3
Age-Related Normogram for Ovarian Antral Follicle Count in Women with Polycystic Ovary Syndrome and Comparison with Age Matched Controls Using Magnetic Resonance Imaging.
2016 · cited by 7
Paper [1] demonstrates that magnetic resonance imaging (MRI) is an effective alternative to transvaginal ultrasound for evaluating ovarian antral follicle counts in patients with PCOS.
See more details
More against · 2
Diagnosis of Polycystic Ovary Syndrome With Predictive Modeling of Select Clinical Features.
2026 · cited by 0
Paper [6] shows that biochemical markers such as anti-Müllerian hormone (AMH) can predict PCOS diagnosis with high accuracy independently of ultrasound.
Evaluating the PCOS risk algorithm (PriskA): a pilot study.
2026 · cited by 0
Paper [9] highlights that blood tests like AMH can replace ultrasound for assessing polycystic ovarian morphology within risk algorithms.